DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® ...
DRI Capital Inc. Updates Executive Changes
2024 Second Quarter Earnings Call
DRI Healthcare Trust Reports Second Quarter 2024 Results
DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024
DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (ol...
Presentation at 2024 RBC Capital Markets Global Healthcare Conference
2024 Annual Meeting of Unitholders